Prevention of Postasphyxia Electroretinal Dysfunction with a Pyridoxal Hydrazone
- 31 December 1997
- journal article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 22 (1-2) , 11-16
- https://doi.org/10.1016/s0891-5849(96)00274-2
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- In vitro antioxidant properties of the iron chelator pyridoxal isonicotinoyl hydrazone and some of its analogsRedox Report, 1995
- Ferrous Ion Strongly Promotes the Ring Opening of the Hydrolysis Intermediates of the Antioxidant Cardioprotective Agent Dexrazoxane (ICRF-187)Archives of Biochemistry and Biophysics, 1995
- Iron‐Melanin Interaction and Lipid Peroxidation: Implications for Parkinson's DiseaseJournal of Neurochemistry, 1991
- Intracellular iron redistributionBiochemical Pharmacology, 1990
- [1] Role of free radicals and catalytic metal ions in human disease: An overviewPublished by Elsevier ,1990
- Early treatment with deferoxamine limits myocardial ischemic/reperfusion injuryFree Radical Biology & Medicine, 1989
- Superoxide dependent iron release from ferritin in inflammatory diseasesFree Radical Biology & Medicine, 1988
- The effect of synovial iron on the progression of rheumatoid diseaseArthritis & Rheumatism, 1984
- Biliary Iron Excretion in Rats following Pyridoxal Isonicotinoyl HydrazoneBritish Journal of Haematology, 1980
- A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agentsBiochimica et Biophysica Acta (BBA) - General Subjects, 1979